{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:10:32Z","timestamp":1761487832809},"reference-count":19,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:00:00Z","timestamp":1179100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Most patients with severe aplastic anemia (sAA) respond to immunosuppression, but a significant number relapse or develop clonal abnormalities such as paroxysmal nocturnal hemoglobinuria, myelodysplasia, or leukemia. In principle, patients without matched sibling donors and older patients might benefit from transplantation of autologous hematopoietic peripheral blood progenitor cells (PBPCs) obtained during remission. Even patients who have clinically recovered from aplastic anemia have diminished hematopoietic progenitor cells, so the practicability of PBPC mobilization in these individuals is unknown.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> The feasibility of PBPC mobilization in nine patients with a history of sAA was evaluated. Granulocyte\u2013colony\u2010stimulating factor (10\u2003\u00b5g\/kg) was administered subcutaneously for 5\u2003days and followed by a 12\u2010L leukapheresis procedure.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Only two of the nine patients had sufficient mobilization of CD34 cells to merit collection; in these cases sufficient CD34 cells were obtained for autologous transplantation should the need arise.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> PBPC collection is feasible only in a fraction of recovered AA patients.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2007.01258.x","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T14:00:05Z","timestamp":1179151205000},"page":"1250-1253","source":"Crossref","is-referenced-by-count":7,"title":["Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells in recovered aplastic anemia patients"],"prefix":"10.1111","volume":"47","author":[{"given":"Elaine M.","family":"Sloand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan F.","family":"Leitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,14]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1134"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.9.1130"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0037-1963(00)90033-7","article-title":"Late clonal diseases of treated aplastic anemia","volume":"37","author":"Socie G","year":"2000","journal-title":"Semin Hematol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.9.3129"},{"issue":"1","key":"e_1_2_5_6_2","first-page":"24b","article-title":"A preliminary report on a randomized trial comparing ATG and cyclosporine vs. cyclophosphamide and cyclosporine as initial treatment for severe aplastic anemia [abstract]","volume":"10","author":"Tisdale JF","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8652(200010)65:2<123::AID-AJH6>3.0.CO;2-M"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0096"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03078.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2002.29245"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1182\/blood.V88.6.1983.bloodjournal8861983","article-title":"A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long\u2010term culture\u2010initiating cells) in acquired aplastic anemia","volume":"88","author":"Maciejewski JP","year":"1996","journal-title":"Blood"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00701.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.07.007"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00361.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V82.5.1410.1410","article-title":"Collection of peripheral blood hematopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony\u2010stimulating factor","volume":"82","author":"Bacigalupo A","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00101-0"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.pm12434950"},{"key":"e_1_2_5_18_2","first-page":"2818","article-title":"Peripheral blood stem cell mobilization after stem cell factor or G\u2010CSF treatment: rapid enrichment for stem and progenitor cells using the CEPRATE immunoaffinity separation system","volume":"24","author":"Heimfeld S","year":"1992","journal-title":"Transplant Proc"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04222.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0663"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2007.01258.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2007.01258.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:33:10Z","timestamp":1695947590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2007.01258.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,14]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1537-2995.2007.01258.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2007.01258.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,14]]}}}